Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Insider Trends: 90-Day Insider Selling Trend Prolonged at Insulet

06/07/2021 | 04:32pm EDT


© MT Newswires 2021
All news about INSULET CORPORATION
07/21INSULET : Cowen Analyst Assumes Coverage on Outperform-Rated Insulet, Sets $310 ..
MT
07/20INSULET : SVB Leerink Adjusts Price Target for Insulet to $325 From $300, Mainta..
MT
07/02INSIDER TRENDS : Insulet Insider Disposition Eases Back 90-Days of Buys
MT
07/01INSULET : to Announce Second Quarter 2021 Financial Results on August 5, 2021
BU
06/28INSULET : Wearable Insulin Delivery System Shows Improved Outcomes in Children i..
MT
06/26INSULET : Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstra..
BU
06/26Insulet Corporation’S Omnipod® 5 Automated Insulin Delivery System Pivotal St..
CI
06/24INSULET : to Present New Clinical Data for Preschool Children and Adults using t..
BU
06/24Insulet Corporation to Present New Clinical Data for Preschool Children and A..
CI
06/22Insulin pump Accessories Market Development, Outline, Competitive perspective..
AQ
More news
Financials (USD)
Sales 2021 1 083 M - -
Net income 2021 46,8 M - -
Net Debt 2021 228 M - -
P/E ratio 2021 384x
Yield 2021 -
Capitalization 18 327 M 18 327 M -
EV / Sales 2021 17,1x
EV / Sales 2022 14,2x
Nbr of Employees 1 900
Free-Float 99,6%
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 276,55 $
Average target price 282,79 $
Spread / Average Target 2,26%
EPS Revisions
Managers and Directors
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
INSULET CORPORATION8.18%18 446
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667